These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1946183)

  • 1. Studies on active transport of (E)-10-hydroxynortriptyline in the kidney and brain of rats: effects of propranolol and quinidine.
    Otani K; Kaneko S; Bertilsson L
    Pharmacol Toxicol; 1991 May; 68(5):380-3. PubMed ID: 1946183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective inhibition of nortriptyline hydroxylation in man by quinidine.
    Pfandl B; Mörike K; Winne D; Schareck W; Breyer-Pfaff U
    Xenobiotica; 1992 Jun; 22(6):721-30. PubMed ID: 1441595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings.
    Dahl-Puustinen ML; Perry TL; Dumont E; von Bahr C; Nordin C; Bertilsson L
    Clin Pharmacol Ther; 1989 Jun; 45(6):650-6. PubMed ID: 2731406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients.
    Bertilsson L; Otani K; Dahl ML; Nordin C; Aberg-Wistedt A
    Pharmacol Toxicol; 1991 Feb; 68(2):100-3. PubMed ID: 1852713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.
    Nordin C; Bertilsson L
    Clin Pharmacokinet; 1995 Jan; 28(1):26-40. PubMed ID: 7712660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantioselective hydroxylation of nortriptyline in human liver microsomes, intestinal homogenate, and patients treated with nortriptyline.
    Dahl ML; Nordin C; Bertilsson L
    Ther Drug Monit; 1991 May; 13(3):189-94. PubMed ID: 1926270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
    Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
    J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects.
    Bertilsson L; Nordin C; Otani K; Resul B; Scheinin M; Siwers B; Sjöqvist F
    Clin Pharmacol Ther; 1986 Sep; 40(3):261-7. PubMed ID: 3742932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF/plasma ratio of 10-hydroxynortriptyline is influenced by sex and body height.
    Nordin C
    Psychopharmacology (Berl); 1993; 113(2):222-4. PubMed ID: 7855185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma 10-hydroxynortriptyline in elderly depressed patients.
    Young RC; Alexopoulos GS; Shamoian CA; Manley MW; Dhar AK; Kutt H
    Clin Pharmacol Ther; 1984 Apr; 35(4):540-4. PubMed ID: 6705454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Little anticholinergic effect of E-10-hydroxynortriptyline compared with nortriptyline in healthy subjects.
    Nordin C; Bertilsson L; Otani K; Widmark A
    Clin Pharmacol Ther; 1987 Jan; 41(1):97-102. PubMed ID: 3802713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probenecid and quinidine on the transport of alovudine (3'-fluorothymidine) to the rat brain studied by microdialysis.
    Lindén K; Ståhle L; Ljungdahl-Ståhle E; Borg N
    Pharmacol Toxicol; 2003 Nov; 93(5):226-32. PubMed ID: 14629734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
    Nordin C; Bertilsson L; Siwers B
    Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of the enantiomers of E-10-hydroxynortriptyline in human and rat liver microsomes.
    Dumont E; von Bahr C; Perry TL; Bertilsson L
    Pharmacol Toxicol; 1987 Nov; 61(5):335-41. PubMed ID: 3125532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
    Ejsing TB; Linnet K
    Hum Psychopharmacol; 2005 Mar; 20(2):149-53. PubMed ID: 15624117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics.
    Nordin C; Bertilsson L; Dahl ML; Resul B; Toresson G; Sjöqvist F
    Psychopharmacology (Berl); 1991; 103(3):287-90. PubMed ID: 2057534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of pharmacokinetic interaction between propranolol and quinidine in rats.
    Yamada K; Yasuhara M; Yatsuzuka A; Okumura K; Sakurai T; Kawai C; Hori R
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1876-9. PubMed ID: 1394707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite.
    Nordin C; Bertilsson L; Siwers B
    Br J Clin Pharmacol; 1985 Oct; 20(4):411-3. PubMed ID: 4074608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinidine reduces clearance of (+)-propranolol more than (-)-propranolol through marked reduction in 4-hydroxylation.
    Zhou HH; Anthony LB; Roden DM; Wood AJ
    Clin Pharmacol Ther; 1990 Jun; 47(6):686-93. PubMed ID: 2357863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cardiotoxicity of nortriptyline and its isomeric 10-hydroxymetabolites.
    Pollock BG; Everett G; Perel JM
    Neuropsychopharmacology; 1992 Jan; 6(1):1-10. PubMed ID: 1571065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.